HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry
See all Insights

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

Co-Author, Cannabis Industry Journal, Sept. 13, 2023

In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under the Controlled Substances Act, should be reclassified as a Schedule III drug. The announcement was made on Wednesday, August 30.

HHS’ conclusion was sent by letter to the Drug Enforcement Administration (DEA), the agency with authority to reclassify how various substances are treated under federal drug laws. The HHS recommendation means that the nation’s top health agency no longer considers cannabis a drug that lacks medical value and carries the high potential for abuse.

Click here to read the full article. 

Recent Insights